Lenalidomide and Docetaxel in Treating Patients With Advanced Solid Tumors
Status:
Completed
Trial end date:
2008-06-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Lenalidomide may stop the growth of tumor cells by blocking blood flow to the
tumor. Drugs used in chemotherapy, such as docetaxel, work in different ways to stop the
growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving
lenalidomide together with docetaxel may kill more tumor cells.
PURPOSE: This phase I trial is studying the side effects and best dose of lenalidomide when
given together with docetaxel in treating patients with advanced solid tumors.